Search results
30 wrz 2024 · This community-based randomized clinical trial integrated H pylori stool antigen (HPSA) screening and treatment with fecal immunochemical testing (FIT) screening to determine whether an invitation to HPSA + FIT could reduce the incidence and mortality of gastric cancer compared with use of FIT alone. Methods.
19 sie 2023 · H. pylori infection is the most severe known risk factor for gastric cancer (GC), which is the second highest cause of cancer-related deaths globally. We conducted a systematic review and meta-analysis to assess the global prevalence of GC in H. pylori-infected individuals.
In susceptible infected hosts, long-standing active chronic gastritis may result in gastric mucosal atrophy with intestinal metaplasia. In a minority, these premalignant mucosal changes progress to dysplasia and clinically silent, early cancer, followed by advanced gastric cancer.
29 sie 2022 · Helicobacter pylori (H. pylori) bacterial infection has long been scrutinized as one of the potential risk factors for the development of pancreatic cancer with quite inconsistent and...
At a population level, the strategy of screen-and-treat for H. pylori infection is most cost-effective in young adults in regions with a high incidence of gastric cancer and is recommended preferably before the development of atrophic gastritis and intestinal metaplasia in high-risk populations.
28 lip 2022 · We examined H. pylori infection risk factors among school children using machine learning algorithms to identify important risk factors as well as to determine whether machine learning can be used to predict H. pylori infection status.
1 sty 2017 · Noninvasive methods, such as the urea breath test (UBT-13C or 14C) and fecal antigen test (FAT), have high sensitivity and specificity for the diagnosis of H. pylori.
